NCT01265394View on ClinicalTrials.gov

Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

218

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

March 31, 2011

Study Completion Date

April 30, 2011

Conditions
Healthy
Interventions
DRUG

[18F] Flutemetamol

Flutemetamol (18F) Injection, 185 MBq/5 mCi, single intravenous injection.

Trial Locations (1)

08540

GE Healthcare, Princeton

Sponsors

Lead Sponsor

GE Healthcare

Collaborators (1)

Medpace, Inc.
All Listed Sponsors
collaborator

i3 Statprobe

INDUSTRY

collaborator

Medpace, Inc.

INDUSTRY

lead

GE Healthcare

INDUSTRY